Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Press Coverage
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
Cellvizio, See Clearly & Act Faster
Cellvizio® is the
first and only
probe-based confocal laser endomicroscopy platform available to healthcare providers worldwide
Provides real-time vision at the cellular level
Cellvizio® helps eliminate uncertainties
related to the
diagnosis and treatment of cancer
and other diseases
Cellvizio, See Clearly & Act Faster
A breakthrough imaging platform
changing
the way physicians and surgeons plan their patients’ treatment
Scroll
You might also like to read
NEWS - Cellvizio
Nov 2, 2023
Mauna Kea Technologies Announces First Patient Enrolled in the Pivotal CLEVER Clinical Trial in Peripheral Lung Cancer
Discover
NEWS - Cellvizio
Oct 31, 2022
Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease (IBD) and its Publication in Gastroenterology
Discover
NEWS - Cellvizio
Jul 6, 2022
Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer
Discover
Find out more by downloading the
Cellvizio Brochure
Discover